leadf
logo-loader
viewOpen Orphan PLC

Venn Life Sciences names new chair

"Allan's experience includes both organic business growth and M&A..," said the CEO

empt_boardroom,_sized_57d7af473c6ed.png
Venn has a new chairman starting on September 20

Allan Wood will become chairman at Venn Life Sciences Holdings plc (LON:VENN) on September 20, replacing Tony Richardson, CEO, who has been acting as executive chairman since the beginning of the year.

Richardson told investors: "I am delighted to welcome Allan to Venn. Allan has extensive relevant experience in scaling businesses in health services and related sectors and I believe will add significant value as we seek to continue our current growth trajectory.

"Allan's experience includes both organic business growth and M&A and together we can continue to build a successful and sustainable business for shareholders."

Shares added 1.79% to 28.5p.

Quick facts: Open Orphan PLC

Price: 15.25 GBX

AIM:ORPH
Market: AIM
Market Cap: £101.51 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Open Orphan PLC named herein, including the promotion by the Company of Open Orphan PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Open Orphan PLC: Proactive One2One Virtual Conference

Open Orphan PLC's (LON:ORPH) Cathal Friel presents at the Proactive One2One Virtual Conference. The company's a rapidly growing specialist CRO pharmaceutical services company which is a world leader in the testing of vaccines and antivirals through the use of human challenge clinical trials. It...

3 weeks ago

2 min read